Mattheos Bobos Selected Research

Mattheos Bobos Research Topics

Disease

54	Neoplasms (Cancer) 10/2022 - 04/2006
36	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2008
6	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2008
4	Carcinoma (Carcinomatosis) 06/2021 - 06/2014
4	Adenocarcinoma 06/2021 - 08/2008
3	Nasopharyngeal Carcinoma 02/2020 - 02/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 09/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 03/2010 - 01/2009
2	Stomach Neoplasms (Stomach Cancer) 06/2021 - 05/2020
2	Sarcoidosis (Schaumann Disease) 01/2021 - 05/2013
2	Melanoma (Melanoma, Malignant) 01/2021 - 02/2020
2	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 01/2018
2	Disease Progression 01/2018 - 11/2006
2	Infections 09/2017 - 11/2006
2	Laryngeal Neoplasms (Laryngeal Cancer) 11/2014 - 04/2014
2	Lymphoma (Lymphomas) 01/2009 - 08/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2009 - 08/2006
1	Erythema Multiforme 11/2022
1	Hyperpigmentation 10/2022
1	Erosive Adenomatosis of the Nipple 05/2022
1	Surgical Wound 05/2022
1	Exanthema (Rash) 01/2020

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2006
22	ParaffinIBA 03/2020 - 08/2008
14	Trastuzumab (Herceptin)FDA Link 10/2022 - 02/2008
14	Messenger RNA (mRNA)IBA 01/2022 - 08/2006
14	Formaldehyde (Formol)FDA Link 01/2018 - 08/2008
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2006
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 06/2010
5	AnthracyclinesIBA 01/2018 - 01/2009
4	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 01/2012
4	Hormones (Hormone)IBA 11/2022 - 01/2012
4	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2010
4	Phenobarbital (Luminal)FDA Link 01/2017 - 01/2014
4	Cadherins (E-Cadherin)IBA 11/2016 - 01/2013
3	Docetaxel (Taxotere)FDA Link 12/2023 - 02/2009
3	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 01/2009
3	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2020 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020 - 01/2013
3	Monoclonal AntibodiesIBA 11/2018 - 08/2008
3	Cyclin D1IBA 01/2017 - 01/2009
3	Vascular Endothelial Growth Factor CIBA 09/2015 - 11/2006
3	Cetuximab (Erbitux)FDA Link 05/2014 - 08/2008
3	taxaneIBA 01/2014 - 05/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 04/2012
2	human ERBB2 proteinIBA 10/2022 - 01/2019
2	LigandsIBA 01/2022 - 11/2014
2	Phosphotransferases (Kinase)IBA 12/2021 - 09/2017
2	Fluorouracil (Carac)FDA LinkGeneric 06/2021 - 04/2012
2	AntigensIBA 08/2019 - 04/2006
2	CateninsIBA 01/2018 - 04/2014
2	CrizotinibIBA 11/2017 - 01/2015
2	Anaplastic Lymphoma KinaseIBA 11/2017 - 01/2015
2	Lapatinib (GW572016)FDA Link 09/2017 - 06/2013
2	Tyrosine Kinase InhibitorsIBA 09/2017 - 09/2012
2	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 01/2013
2	Keratin-5 (Keratin 5)IBA 05/2016 - 01/2012
2	Taxoids (Taxanes)IBA 01/2016 - 06/2015
2	TOR Serine-Threonine KinasesIBA 01/2016 - 07/2014
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2015 - 01/2013
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 09/2015 - 01/2013
2	RNA (Ribonucleic Acid)IBA 05/2015 - 01/2015
2	Thymidylate SynthaseIBA 09/2014 - 09/2009
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2014 - 09/2009
2	Oncogene Proteins (Oncogene Protein)IBA 01/2014 - 04/2006
2	Temozolomide (Temodar)FDA LinkGeneric 06/2013 - 11/2006
2	Progesterone Receptors (Progesterone Receptor)IBA 05/2013 - 01/2012
2	Estrogen ReceptorsIBA 05/2013 - 01/2012
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2013 - 10/2012
2	Gefitinib (Iressa)FDA Link 01/2010 - 10/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2009 - 11/2006
1	antineoplaston A10 (A 10)IBA 11/2022
1	ribociclibIBA 11/2022
1	abemaciclibIBA 11/2022
1	palbociclibIBA 11/2022
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	Cyclin-Dependent Kinase 4IBA 11/2022
1	SteroidsIBA 10/2022
1	tyrosine receptor (receptor, tyrosine)IBA 12/2021
1	Eph Family Receptors (Eph Receptors)IBA 12/2021
1	AfatinibIBA 06/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	fas Receptor (CD95 Antigen)IBA 02/2020
1	tributyl phosphate (TBP)IBA 02/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 02/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 02/2020
1	Bortezomib (Velcade)FDA Link 01/2020

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 12/2023 - 11/2006
12	Adjuvant Chemotherapy 11/2022 - 09/2009
7	Therapeutics 11/2022 - 05/2013
3	Radiotherapy 09/2017 - 01/2009
2	Mastectomy (Mammectomy) 11/2016 - 06/2010
2	Semiconductors 05/2016 - 01/2016
1	Sutures (Suture) 05/2022
1	Immunotherapy 01/2021
1	Adjuvant Chemoradiotherapy 05/2020